Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Option Activity (Details)

v3.22.2.2
Schedule of Stock Option Activity (Details) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]        
Number of Options, Beginning Balance 464,019 151,277 151,277  
Weighted average exercise price, Beginning Balance $ 20.95 $ 9.10 $ 9.10  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 8 years 2 months 12 days 8 years 9 months 18 days 7 years 4 months 24 days 8 years 8 months 12 days
Number of Options, Granted 148,860 256,187    
Weighted average exercise price, Granted $ 5.02 $ 22.70    
Number of Options, Additional options grant StemoniX holders   38,376    
Weighted average exercise price, Additional options grant StemoniX holders   $ 23.05    
Number of Options, assumed in Merger   11,168    
Weighted average exercise price, Options assumed in Merger   $ 229.75    
Number of Options, Exercised (1,034) (5,983)    
Weighted average exercise price, Exercised $ 4.80 $ 6.20    
Number of Options, Forfeited (94,364) (18,217)    
Weighted average exercise price, Forfeited $ 14.94 $ 19.10    
Number of Options, Expired (32,700) (2,241)    
Weighted average exercise price, Expired $ 42.51 $ 7.25    
Number of Options, Ending Balance 484,781 430,567 464,019 151,277
Weighted average exercise price, Ending Balance $ 15.34 $ 23.80 $ 20.95 $ 9.10
Number of Options, Exercisable 198,844      
Weighted average exercise price, Exercisable $ 19.58      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 1 month 6 days